Calumet, Inc. /DE earns about -5% on invested capital, but has diluted owners by 9% over 4 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below. Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Revenue | $4.69B1 | $4.18B2 | $4.19B2 | $4.14B2 |
| Net income | −$173.3M3 | $48.1M4 | −$222M4 | −$33.8M4 |
| Operating cash flow | $100.6M5 | −$14.9M6 | −$46.4M6 | $108.9M6 |
| Capital expenditure | $536.2M7 | $271.8M8 | $76.7M8 | $52.3M8 |
| Free cash flow (derived) | −$435.6M5,7 | −$286.7M6,8 | −$123.1M6,8 | $56.6M6,8 |
| Total debt | — | $1.83B9 | $2.12B10 | $2.23B11 |
| Cash & equivalents | $35.2M12 | $7.9M13 | $38.1M13 | $125.1M13 |
| Diluted shares | 79.3M | 80.1M | 83.1M | 86.8M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom). A derived or summed figure cites every filing line it was built from.
10 shares is a claim on −$84.45 of net worth that earned you −$3.9 and generated $6.52 of cash last year, against $257.43 of debt.
It earned an average -5% on invested capital over 4 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 9% over 4 years — owners have been diluted. Worth asking what they got for it. Total debt has risen 22% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
This page is free, and so is every other company on MeritValue.
Connect the MeritValue MCP server to Claude or another MCP client, ask about Calumet, Inc. /DE, and get these exact figures with their filing receipts — not an improvised DCF.
Get a free key →Pull the companies with a published value under any model (up to 500 a request, filtered by data completeness) into your own sheet or agent. Screening is what Analyst adds, at $9/month.
See pricing →Follow CLMT and keep your own price beside the value. The same engine, with the same receipts.
MeritValue on the App Store →- 10-K filed 2025-03-03 · period ending 2022-12-31 · accession 0001558370-25-001961 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K filed 2026-02-27 · periods ending 2023-12-31, 2024-12-31, 2025-12-31 · accession 0002013745-26-000007 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K filed 2025-03-03 · period ending 2022-12-31 · accession 0001558370-25-001961 (NetIncomeLoss)
- 10-K filed 2026-02-27 · periods ending 2023-12-31, 2024-12-31, 2025-12-31 · accession 0002013745-26-000007 (NetIncomeLoss)
- 10-K filed 2025-03-03 · period ending 2022-12-31 · accession 0001558370-25-001961 (NetCashProvidedByUsedInOperatingActivities)
- 10-K filed 2026-02-27 · periods ending 2023-12-31, 2024-12-31, 2025-12-31 · accession 0002013745-26-000007 (NetCashProvidedByUsedInOperatingActivities)
- 10-K filed 2025-03-03 · period ending 2022-12-31 · accession 0001558370-25-001961 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K filed 2026-02-27 · periods ending 2023-12-31, 2024-12-31, 2025-12-31 · accession 0002013745-26-000007 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K filed 2025-03-03 · period ending 2023-12-31 · accession 0001558370-25-001961 (LongTermDebtNoncurrent)
- 10-K filed 2025-03-03 · period ending 2024-12-31 · accession 0001558370-25-001961 (LongTermDebt)
- 10-K filed 2026-02-27 · period ending 2025-12-31 · accession 0002013745-26-000007 (LongTermDebt)
- 10-K filed 2025-03-03 · period ending 2022-12-31 · accession 0001558370-25-001961 (CashAndCashEquivalentsAtCarryingValue)
- 10-K filed 2026-02-27 · periods ending 2023-12-31, 2024-12-31, 2025-12-31 · accession 0002013745-26-000007 (CashAndCashEquivalentsAtCarryingValue)